European Journal of Preventive Cardiology and secondary cardiovascular prevention and sport cardiology. It publishes 18 issues yearly and abstracted and indexed in Scopus and the Social Sciences Citation Index. According to the "Journal Citation Reports", its 2016 impact factor is 3.6, ranking it 43th out of 125 journals in the category "Cardiac & Cardiovascular Systems". Areas of interests are Cardiovascular primary and secondary preventions, (including arterial hypertension, dyslipidaemia, diabetes, obesity, smoking cessation, healthy life style promotion), epidemiology, cardiac rehabilitation, exercise training and physiology, sport cardiology, population science intervention. European Journal of Preventive Cardiology The European Journal of Preventive Cardiology is a peer-reviewed medical journal that
Cardiovascular disease risk of cardiovascular disease over the next ten years. Niacin, fibrates and CETP Inhibitors, while they may increase HDL cholesterol do not affect the risk of cardiovascular disease in those who are already on statins. Anti-diabetic medication may reduce cardiovascular risk in people with Type 2 Diabetes, although evidence is not conclusive. A meta-analysis in 2009 including 27,049 participants and 2,370 major vascular events showed a 15% relative risk reduction in cardiovascular disease with more-intensive glucose lowering over an average follow-up period of 4.4 years, but an increased risk of major hypoglycemia. Aspirin has been found to be of only